TMO THERMO FISHER SCIENTIFIC INC.
Measuring & Controlling Devices, NEC · NYSE · SEC CIK 97745 · Fiscal year ends 12/31
Financial factors as of 2026-09-26 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY8.3%
TTM net income YoY7.6%
TTM EPS YoY9.5%
Revenue 3-yr CAGR2.9%
Net income 3-yr CAGR6.0%
Margins
Gross margin—
Operating margin17.9%
Net margin14.9%
FCF margin16.0%
EBITDA margin20.5%
Returns
ROE13.4%
ROA6.5%
ROIC (approx.)8.8%
Asset turnover0.44x
Leverage & solvency
Liabilities / assets51.9%
Debt / equity0.76x
Current ratio1.81x
Interest coverage5.51x
Cash quality & payout
Operating cash flow / net income1.32x
Accruals ratio-2.1%
Payout ratio9.5%
Capex / revenue3.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $44.56B | $42.88B |
| R&D expense | $1.40B | $1.39B |
| SG&A expense | $8.73B | $8.60B |
| Operating income | $7.75B | $7.34B |
| Interest expense | $1.42B | $1.39B |
| Pretax income | $7.31B | $7.04B |
| Income tax | $547.00M | $657.00M |
| Net income | $6.70B | $6.33B |
| EBITDA | $8.80B | $8.49B |
| EPS (basic) | 17.77 | 16.58 |
| EPS (diluted) | 17.74 | 16.53 |
| Dividends declared per share | 1.72 | 1.56 |
| Weighted avg. shares (diluted) | 378.00M | 383.00M |
| Balance sheet | ||
| Cash & equivalents | $9.85B | $4.04B |
| Short-term investments | $253.00M | $1.56B |
| Receivables | $8.90B | $8.19B |
| Inventory | $5.42B | $4.98B |
| Current assets | $28.71B | $22.14B |
| PP&E, net | $10.56B | $9.31B |
| Goodwill | $49.36B | $45.85B |
| Intangibles | $15.84B | $15.53B |
| Total assets | $110.34B | $97.32B |
| Current liabilities | $15.19B | $13.33B |
| Short-term debt | $3.53B | $2.21B |
| Long-term debt | $35.85B | $29.06B |
| Total debt | $39.38B | $31.27B |
| Total liabilities | $56.81B | $47.65B |
| Shareholders' equity | $53.41B | $49.58B |
| Net debt | $29.53B | $27.23B |
| Cash flow statement | ||
| Operating cash flow | $7.82B | $8.67B |
| Capital expenditure | $1.52B | $1.40B |
| Free cash flow | $6.29B | $7.27B |
| Investing cash flow | -$4.05B | -$5.84B |
| Financing cash flow | $1.80B | -$6.79B |
| Depreciation & amortization | $1.05B | $1.16B |
| Stock-based compensation | $310.00M | $301.00M |
| Dividends paid | $636.00M | $583.00M |
| Share buybacks | $3.00B | $4.00B |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.